These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16413684)

  • 21. Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma.
    Boffa LC; Menichini P; Bolognesi C; Cutrona G; Roncella S; Damonte GL; Millo E; Mariani MR; Matis S; Russo D; Ciliutti P; Ferrarini M
    Mutat Res; 2007 Apr; 628(2):129-37. PubMed ID: 17267263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An unusual p53 mutation detected in Burkitt's lymphoma: 30 bp duplication.
    Smardova J; Grochova D; Fabian P; Moulis M; Smarda J; Falkova I; Ravcukova B; Vankova J; Vasova I
    Oncol Rep; 2008 Oct; 20(4):773-8. PubMed ID: 18813817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of apoptosis and cell-proliferation regulating genes in mycosis fungoides.
    Kandolf Sekulović L; Cikota B; Jović M; Skiljević D; Stojadinović O; Medenica L; Magić Z
    J Dermatol Sci; 2009 Jul; 55(1):53-6. PubMed ID: 19324523
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutant mice lacking alternatively spliced p53 isoforms unveil
    Fajac A; Simeonova I; Leemput J; Gabriel M; Morin A; Lejour V; Hamon A; Rakotopare J; Vaysse-Zinkhöfer W; Eldawra E; Pinskaya M; Morillon A; Bourdon JC; Bardot B; Toledo F
    Elife; 2024 Sep; 13():. PubMed ID: 39298333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic sequencing studies in Burkitt's lymphoma: what can we learn about tumorigenesis?
    Soldini D; Campo E
    Expert Rev Hematol; 2013 Jun; 6(3):219-21. PubMed ID: 23782073
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological activities of p53 mutants in Burkitt's lymphoma cells.
    Vousden KH; Crook T; Farrell PJ
    J Gen Virol; 1993 May; 74 ( Pt 5)():803-10. PubMed ID: 8492087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The cytotoxicity and mechanism of CIK cells to breast cancer cells ZK-75-1].
    Li XD; Sun S; Song LL; Yang WS; Jin TF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):314-7. PubMed ID: 16643788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CUL7 is a novel antiapoptotic oncogene.
    Kim SS; Shago M; Kaustov L; Boutros PC; Clendening JW; Sheng Y; Trentin GA; Barsyte-Lovejoy D; Mao DY; Kay R; Jurisica I; Arrowsmith CH; Penn LZ
    Cancer Res; 2007 Oct; 67(20):9616-22. PubMed ID: 17942889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression of c-Myc and p53 as a marker of survival time.
    Vollmer RT
    Am J Clin Pathol; 2000 Dec; 114(6):983-5. PubMed ID: 11338487
    [No Abstract]   [Full Text] [Related]  

  • 30. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.
    Sundberg TB; Ney GM; Subramanian C; Opipari AW; Glick GD
    Cancer Res; 2006 Feb; 66(3):1775-82. PubMed ID: 16452238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

  • 32. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression.
    Manna S; Banerjee S; Mukherjee S; Das S; Panda CK
    Apoptosis; 2006 Dec; 11(12):2267-76. PubMed ID: 17041754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased level of Oct-1 protein in tumor cells modulates cellular response to anticancer drugs.
    Portseva TN; Pankratova EV; Stepchenko AG; Georgieva SG
    Dokl Biochem Biophys; 2016 Jul; 469(1):269-72. PubMed ID: 27599509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
    Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
    Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
    Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line.
    Gu CM; Zhu YK; Ma YH; Zhang M; Liao B; Wu HY; Lin HL
    Neoplasma; 2006; 53(3):206-12. PubMed ID: 16652189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The c-myc promoter: still MysterY and challenge.
    Wierstra I; Alves J
    Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inauhzin(c) inactivates c-Myc independently of p53.
    Jung JH; Liao JM; Zhang Q; Zeng S; Nguyen D; Hao Q; Zhou X; Cao B; Kim SH; Lu H
    Cancer Biol Ther; 2015; 16(3):412-9. PubMed ID: 25692307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.